Find clinical trials for Ovarian Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Hanyang, Seoul, KOR:
This is a randomized phase II study of secondary cytoreductive surgery (CRS) in patients with relapsed ovarian cancer who have prog...
Phase 2
Seoul, Korea, Republic of
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Seoul, Korea, Republic of and 125 other locations
adult subjects with CA125-associated, advanced recurrent epithelial ovarian, fallopian tube or peritoneal carcinoma (FIGO Stage III/IV) with...
Phase 1, Phase 2
Seoul, Korea, Republic of and 5 other locations
the pharmacokinetics and safety of BR2022 and BR2022-1 in Patients with deleterious or suspected deleterious germline BRCA-mutated advanced ovarian...
Phase 1
Seoul, Seoul, South Korea
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Seoul, Korea, Republic of and 213 other locations
of alpelisib and olaparib compared with single agent cytotoxic chemotherapy in patients with platinum resistant or refractory high-grade serous ovarian...
Phase 3
Seoul, Korea, Republic of and 92 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Seoul, Korea, Republic of and 176 other locations
therapy for the treatment of participants with advanced/recurrent ovarian cancer.Substudy 1 will investigate the safety, tolerabili...
Phase 1, Phase 2
Seoul, Korea, Republic of and 22 other locations
as "study drug". The study is focused on patients who have advanced ovarian cancer.The aim of the study is to see how safe, tolerab...
Phase 2
Seoul, Korea, Republic of and 5 other locations
A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer...
Phase 2, Phase 3
Seoul, Korea, Republic of and 38 other locations
Clinical trials
Research sites
Resources
Legal